No Infections Seen After Transperineal Biopsy for Prostate Cancer
Similar cancer detection rates seen for transperineal versus transrectal biopsy, but reduction in infections seen for transperineal
Cancer Incidence Rates in 2021 Indicate Return to Prepandemic Levels
Recovery incorporating the delayed diagnoses from 2020 was not seen for overall cancer incidence
Omitting Biopsy With Negative MRI Reduces Detection of Clinically Insignificant Prostate Cancer
More than half of diagnoses of clinically insignificant prostate cancer eliminated by omitting biopsy in men with negative MRI
Cognitive Behavioral Therapy Program Aids Insomnia in Breast Cancer Survivors
Intervention includes six-week in-home, voice-activated cognitive behavioral therapy program
Non-Hispanic Black Patients Have Disparities in HCT Use for Hematologic Cancers
For AML and MDS, lower utilization seen for non-Hispanic Black patients compared with other groups
Melanoma Risk Increased After Radioactive Iodine Treatment for Primary Thyroid Cancer
Standardized incidence ratios elevated for all nonkeratinocyte skin cancers, melanoma
Fidanacogene Elaparvovec Superior to Prophylaxis for Hemophilia B
Adeno-associated virus gene-therapy vector for hemophilia B superior for reducing annualized bleeding rate
Early Adoption of DOAC Dashboard Reduces Off-Label Prescribing
Adoption of DOAC population management tool dashboard before July 2018 linked to decline in off-label dosing prescriptions
Risk for Stroke, TIA Increased in Adults With Sickle Cell Disease
Cumulative incidence of first ischemic stroke was 2.1 percent by age 20 years, 13.5 percent by age 60 years
Wearable Tied to Better Physical Activity Recovery Following Lung Cancer Surgery
Better outcomes also seen for dyspnea compared with controls
